Effect of zinc in animal models of anxiety, depression and psychosis

Human and Experimental Toxicology

Volumn 31, Issue 12, 2012, Pages 1237-1243

  Joshi, M ^a   Akhtar, M ^a   Najmi, A K ^a   Khuroo, A H ^b   Goswami, D ^a  

^a HAMDARD UNIVERSITY   (India)

^b RANBAXY RESEARCH LABORATORIES   (India)

Author keywords

anxiety; depression; NMDA antagonist; psychosis

Indexed keywords

AMPHETAMINE; DIAZEPAM; HALOPERIDOL; IMIPRAMINE; NEUROLEPTIC AGENT; ZINC CHLORIDE;

ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ANXIETY DISORDER; ARM MOVEMENT; ARTICLE; CATALEPSY; CONTROLLED STUDY; DEPRESSION; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG SAFETY; EXTRAPYRAMIDAL SYMPTOM; FORCED SWIMMING TEST; IMMOBILIZATION; LOCOMOTION; LOW DRUG DOSE; MAZE TEST; MOUSE; NONHUMAN; OPEN ARM; PLUS MAZE TEST; PRIORITY JOURNAL; PSYCHOSIS; RAT; RODENT; SINGLE DRUG DOSE; STEREOTYPY; SWIMMING; TRANQUILIZING ACTIVITY; VELOCITY;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM AGENTS; CHLORIDES; DEPRESSION; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FREEZING REACTION, CATALEPTIC; HALOPERIDOL; INJECTIONS, INTRAPERITONEAL; MALE; MAZE LEARNING; MICE; MOTOR ACTIVITY; PSYCHOTIC DISORDERS; RATS; RATS, WISTAR; SWIMMING; ZINC COMPOUNDS;

ANIMALIA; MUS; RODENTIA;

EID: 84871544700     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327112444938     Document Type: Article

References (32)

1. Bray MT, Betteger WJ. The physiological role of zinc as antioxidant. Free Rad Biol Med. 1990 ; 8: 281-291
2. Tran TQ, Ho HL, Chai F, Zalewski DP. Cellular gene fluxes and the regulation of apoptosis/gene-directed cell death. J Nutr. 2000 ; 130: 1459S - 1466S
3. Mohamed AG, Papapetropoulos A, Catravas DJ, Caldwell WR. Zn2+ inhibits nitric oxide formation in response to lipopolysaccharides: implication in its anti-inflammatory activity. Eur J Pharmacol. 1998 ; 341: 265-272
4. Sandstead HH, Frederickson JC, Penland GJ. History of zinc as related to brain function. J Nutr. 2000 ; 130: 496S - 502S
5. Takeda A. Zinc Homeostasis and functions in the brain. Biometals. 2001 ; 14: 343-352
6. Sandstead HH. Zinc: essentiality for brain development and function. Nutr Rev. 1985 ; 43 (5). 130-137
7. Tassabehji MN, Corniola SR, Alshingiti A, Levenson WC. Zinc deficiency induces depression-like symptoms in adult rats. Physiol Behav. 2008 ; 95: 365-369
8. Peters S, Koh J, Choi DW. Zinc selectively blocks the action of N-methyl-D-aspartate on cortical neurons. Science. 1987 ; 236: 589-593
9. Kroczka B, Branski P, Palucha A, Pilc A, Nowak G. Antidepressant-like properties of zinc in rodent forced swim test. Brain Res Bull. 2001 ; 55: 297-300
10. Lobato KR, Binfare WR, Budni J, Rosa O, Santos SRA, Rodriguesn SLA. Involvement of the adenosine A1 and A2A receptors in the antidepressant-like effect of zinc in the forced swimming test. Prog Neuropsychopharmacol Biol Psychiatry. 2008 ; 32: 994-999
11. Christine WC, Choi WD. Effect of zinc on NMDA receptor-mediated channel currents in cortical neurons. J Neurosci. 1990 ; 10: 108-116
12. Takeda A. Movement of zinc and its functional significance in brain. Brain Res Rev. 2000 ; 34: 137-148
13. Takeda A, Tamano H, Fumika Kan, Itoh H, Oku N. Anxiety-like behavior of young rats after 2 week zinc deprivation. Behav Brain Res. 2007 ; 177: 1-6
14. Digirolamo AM, Ramirez ZM, Wang M, Flores AR, Martorell R, Neufeld LM, et al. Randomized trial of the effect of zinc supplementation on the mental health of school-age children in Guatemala. Am J Clin Nutr. 2010 ; 92: 1241-1250
15. Andrews RC. Unification of the findings in schizophrenia by reference to the effects of gestational zinc deficiency. J Med Hypotheses. 1990 ; 31: 141-153
16. Nechifor M, Vaideanu C, Palamaru I, Borza C, Mindreci I. The influence of some antipsychotics on erythrocyte magnesium and plasma magnesium, calcium, copper and zinc in patients with paranoid schizophrenia. J Am Coll Nutr. 2004 ; 3: 549S - 551S
17. Yanik M, Kocyigit A, Tutkun H, Vural H, Herken H. Plasma manganese, selenium, zinc, copper, and iron concentrations in patients with schizophrenia. Biol Trace Elem Res. 2004 ; 98: 109-117
18. Cryan FJ, Mrakou A, Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci. 2002 ; 23: 238-245
19. Lister RG. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology. 1987 ; 92: 180-185
20. Akhtar M, Uma Devi P, Ali A, Pillai KK, Vohora D.. Antipsychotic-like profile of thioperamide. A selective H3 receptor antagonist in mice. Fund Clin Pharmacol. 2006 ; 20: 373-378
21. Plaznik A, Palejko W, Nazar M, Jessa M. Effects of antagonists at the NMDA receptor complex in two models of anxiety. Eur Neuropsychopharmacol. 1994 ; 4: 503-512
22. Wiley LJ, Cristello FA, Balster LR. Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice. Eur J Pharmacol. 1995 ; 294: 101-107
23. Nowak G, Szewczyk B, Wieronska MJ, Branski P, Palucha A, Pilcm A, et al. Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats. Brain Res Bull. 2003 ; 61: 159-164
24. Poleszak E, Szewczyk B, Kedzierska E, Wlaz P, Pilc A, Nowak G. Antidepressant and anxiolytic-like activity of magnesium in mice. Pharmacol Biochem Behav. 2004 ; 78: 7-12
25. Piotrowska A, Mlyniec K, Siwek A, Dybala M, Opoka M, Poleszak A, et al. Antidepressant-like effect of chromium chloride in the mouse forced swim test: involvement of glutamatergic and serotonergic receptors. Pharmacol Rep. 2008 ; 60: 991-995
26. Barkus C, McHugh BS, Sprengel R, Seeburg HP, Rawlins PNJ, Bannerman MD. Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion. Eur J Pharmacol. 2010 ; 626: 49-56
27. Cunha PM, Machado GD, Bettio BEL, Capra CJ, Rodrigues SLA. Interaction of zinc with antidepressants in the tail suspension test. Prog Neuropsychopharmacol Biol Psychiatry. 2008 ; 32: 1913-1920
28. Szewczyk B, Branski P, Wieronska MJ, Palucha A, Pil A, Nowak G. Interaction of zinc with antidepressants in the forced swimming test in mice. Polish J Pharmacol. 2002 ; 54: 681-685
29. Szewczyk B, Poleszak E, Kucma SM, Siwek M, Dudek D, Pokrasniewicz RB, et al. Antidepressant-like effect of chromium chloride in the mouse forced swim test: involvement of glutamatergic and serotonergic receptors. Pharmacol Rep. 2008 ; 60: 588-599
30. Takeda A, Itoh H, Imano S, Oku N. Impairment of GABAergic neurotransmitter in amydala of young rats after 4 week zinc deprivation. Neurochem Int. 2006 ; 49: 746-750
31. Horrobin FD. Schizophrenia: reconciliation of the dopamine, prostaglandin, and opioid concepts and the role of the pineal. Lancet. 1979 ; 313: 529-531
32. Smith SR. The GIT-lymphocyte theory of schizophrenia: some new observations. Med Hypotheses. 1992 ; 37: 27-30